A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)

N/ACompletedNCT01219946

AstraZeneca700 enrolled

Overview

Chronic obstructive pulmonary disease (COPD) is characterized by a progressive decline in lung function and increased symptoms such as breathlessness/dyspnoea, cough and expectoration. Even though subjective in nature, the symptomatology of COPD and mainly that of breathlessness/dyspnoea has been studied with the use of objective measurement tools. Taking into consideration that the symptoms experienced by the patient who suffers from a progressive disease such as COPD can only be perceived and interpreted by the patient him- or herself, and thus difficult to be quantified, COPD remains a challenge in clinical research. Therefore, there is a need to carry out qualitative studies that will provide insight into the wide spectrum of COPD symptomatology from the patient's perspective. In addition, a further mapping of the impact that COPD symptoms' perception has on a patient's life is required, as well as of the different pathways through which symptoms' perception is interpreted regarding the limitations of daily living activities, and the subsequent impact on disease management. The more the physician learns on the embodied experience of COPD, the better he/she may assist the patient in achieving optimal COPD management. Thus this cross-sectional observational study was designed aiming to obtain these data. Specifically, the study aims to evaluate the most frequently used words by the patients and the physicians to express the symptoms of COPD as well as the limitation of activities that it causes.

Study Type

OBSERVATIONAL

Enrollment

700

Conditions

Chronic Obstructive Pulmonary Disease

Eligibility

Sex: ALLMin age: 45 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged 45-75 years * Current or former smokers * Known history of COPD for at least 6 months before enrolment into the study documented by spirometry (FEV1 /FVC \<70%) * Patients with stable COPD (no exacerbation within the last month before enrolment into the study) under treatment with a long-acting inhaled bronchodilator (LABA and/or LAMA) alone or in combination with an inhaled corticosteroid * Written consent for participation in the study * Patients who are able to complete by themselves in Greek a questionnaire on COPD. Exclusion Criteria: * Patients with diagnosed Asthma * Patients with any psychiatric, neurological or other disorder render them unable to complete the COPD questionnaire by themselves * The patient participates in another study.

Locations (32)

Research Site

Athens, Attica, Greece

Research Site

Kallithea, Attica, Greece

Research Site

Marousi, Attica, Greece

Research Site

Megara, Attica, Greece

Research Site

Nea Ionia, Attica, Greece

Research Site

Nea Makri, Attica, Greece

Research Site

Piraeus, Attica, Greece

Research Site

Chania, Crete, Greece

Research Site

Heraklion, Crete, Greece

Research Site

Rhodes, Dodekanisa, Greece

...and 22 more locations

Outcomes

Primary Outcomes

Words used by the patients and the physicians to express the symptoms of COPD as well as the limitations of patients' daily living activities caused by COPD.